Tarsons Products Limited - Asset Resilience Ratio
Tarsons Products Limited (TARSONS) has an Asset Resilience Ratio of 0.19% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See TARSONS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2026)
This chart shows how Tarsons Products Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Tarsons Products Limited's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Tarsons Products Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read TARSONS total debt and obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs22.19 Million | 0.19% |
| Total Liquid Assets | Rs22.19 Million | 0.19% |
Asset Resilience Insights
- Limited Liquidity: Tarsons Products Limited maintains only 0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tarsons Products Limited Industry Peers by Asset Resilience Ratio
Compare Tarsons Products Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050 |
Medical Instruments & Supplies | 1.51% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Pro-Dex Inc
NASDAQ:PDEX |
Medical Instruments & Supplies | 1.39% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for Tarsons Products Limited (2019–2026)
The table below shows the annual Asset Resilience Ratio data for Tarsons Products Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.19% | Rs22.19 Million ≈ $239.98K |
Rs11.86 Billion ≈ $128.24 Million |
+0.14pp |
| 2025-03-31 | 0.05% | Rs5.21 Million ≈ $56.34K |
Rs10.80 Billion ≈ $116.80 Million |
-0.52pp |
| 2024-03-31 | 0.57% | Rs55.01 Million ≈ $594.91K |
Rs9.72 Billion ≈ $105.14 Million |
+0.43pp |
| 2023-03-31 | 0.13% | Rs9.65 Million ≈ $104.36K |
Rs7.26 Billion ≈ $78.48 Million |
-1.41pp |
| 2022-03-31 | 1.54% | Rs83.77 Million ≈ $905.94K |
Rs5.44 Billion ≈ $58.86 Million |
+1.26pp |
| 2021-03-31 | 0.27% | Rs8.13 Million ≈ $87.92K |
Rs2.96 Billion ≈ $32.01 Million |
-0.10pp |
| 2020-03-31 | 0.38% | Rs9.41 Million ≈ $101.77K |
Rs2.49 Billion ≈ $26.90 Million |
+0.17pp |
| 2019-03-31 | 0.21% | Rs4.37 Million ≈ $47.26K |
Rs2.12 Billion ≈ $22.92 Million |
-- |
About Tarsons Products Limited
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers assay plates, biohazard and safetyware, bioprocessing solutions, bottles and carboys, boxes and racks, cell culture ware, centrifuge ware, clamps and stands, clinical and microbiology products, cryoware, desiccators, tubings and connectors, filtration products, … Read more